FDA Warns Ozempic, Wegovy, and Other GLP-1 Drugs May Cause Permanent Vision Loss
Announcement from a bar association
Headline as published by Illinois Lawyer Now (ISBA) on Nov 12, 2026; collected by the wire Nov 12, 2026, 10:16 AM ET.
The FDA warns Ozempic, Wegovy, and other GLP-1 drugs may cause permanent vision loss. It is requiring new safety warnings on the popular weight loss and diabetes medications after finding evidence of an increased risk of a serious eye condition that can cause blindness. The November 9, 2026, announcement affects medications including Ozempic, Wegovy, Mounjaro,... Continue Reading
Coverage
Named in this story
- AgencyU.S. Food and Drug AdministrationMatched on
FDA
Topics
- Recalls and safety alertsMatched on
safety warnings
Explore the named firms, organizations and MDL dockets above. Sources and method